Could Metformin side effects be a thing of the past? 30 January 2017 Could Metformin side effects be a thing of the past? Researchers hope some side effects of metformin, such as unusual tiredness, nausea, vomiting and diarrhoea, could be a thing of the past if they can answer one of the remaining riddles associated with the drug. Dr Tongzhi Wu, from the University of Adelaide, was recently awarded a 芒果直播 Research Program grant to help study how metformin is absorbed into the body and how it lowers blood glucose levels. 鈥淢etformin is one of the most widely prescribed drugs in Australia. It is safe and effective but there are still some things we don鈥檛 know,鈥 Dr Wu says. 鈥淔or example, taking metformin in tablet form is far more effective in lowering blood glucose levels than taking it intravenously. This is opposite to the way most drugs work. 鈥淚 think it has something to do with how metformin interacts with the gastrointestinal tract 鈥 the stomach and the intestines. 鈥淭his is why metformin needs to be taken in relatively large quantities compared with other drugs.鈥 Dr Wu said he hoped his research would contribute to the development of new ways of administering the drug. 鈥淚f we can work out why the reaction with the 鈥榞ut鈥 is so important to how metformin lowers blood glucose levels, then that knowledge will lead to new, more targeted ways of taking the drug,鈥 Dr Wu said. 鈥淏etter targeting could mean smaller doses and this could reduce the likelihood of developing adverse effects like nausea and diarrhoea.” The 芒果直播 Research Program was established in 1987 to support and develop diabetes related research across Australia. The program provides funding towards the prevention, management and cure of all types of diabetes, as well as enabling and fostering young and upcoming researchers in the field of diabetes research. Each year outstanding research projects are selected through a merit based, competitive, peer review process.
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has聽updated聽GLP-1 RA聽product warnings聽because of their聽potential聽to cause a rare but severe eye disorder.聽 The glucagon-like peptide-1 receptor agonist... Continue Reading
News 3 July 2026 Daonil to be discontinued in Australia People living with type 2 diabetes who use Daonil are encouraged to speak with their doctor or diabetes healthcare team... Continue Reading
News 30 June 2026 PBS listing of Tresiba聽Penfill聽good news聽for people living with type 1 diabetes 芒果直播 has welcomed the Australian Government鈥檚 decision to list Tresiba Penfill (insulin degludec) on the Pharmaceutical Benefits Scheme (PBS) for people... Continue Reading